Literature DB >> 7835974

Reduced galactosyltransferase mRNA levels are associated with the agalactosyl IgG found in arthritis-prone MRL-lpr/lpr strain mice.

P A Jeddi1, T Lund, K B Bodman, N Sumar, P M Lydyard, L Pouncey, L S Heath, V J Kidd, P J Delves.   

Abstract

MRL-lpr/lpr strain mice have defectively glycosylated IgG. This may be related to the rheumatoid arthritis (RA)-like disease that occurs in these mice, because a similar glycosylation defect is seen in human subjects with RA. Whilst it is known that this defect is associated with reduced activity of the beta-1,4-galactosyltransferase (beta-1,4-GalTase) enzyme, the cause of this reduced activity is at present unknown. We have therefore examined the molecular genetics of beta-1,4-GalTase in MRL-lpr/lpr mice. Using 10 different restriction endonucleases we found no evidence for a polymorphic variant of the gene in glycosylation-defective mice. However, the level of mRNA for beta-1,4-GalTase was lowest in the MRL-lpr/lpr mice, the strain with the most poorly galactosylated IgG of the four strains examined. Thus, the reduced level of IgG oligosaccharide galactosylation found in MRL-lpr/lpr strain mice appears to be related to either an altered transcriptional level of, or altered mRNA stability for, beta-1,4-GalTase in lymphocytes from these mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835974      PMCID: PMC1415030     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG.

Authors:  S J Thompson; Y Hitsumoto; Y W Zhang; G A Rook; C J Elson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro.

Authors:  K B Bodman; N Sumar; L E Mackenzie; D A Isenberg; F C Hay; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

3.  Aberrant expression of Forssman and Paul-Bunnell antigens on lymph node cells of MRL/Mp-lpr/lpr mice.

Authors:  T Katagiri; T Mori; T Nakano; K Ueno; K Kano
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

4.  Biological significance of carbohydrate chains on monoclonal antibodies.

Authors:  M Nose; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

5.  Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis.

Authors:  I B Wilson; F M Platt; D A Isenberg; T W Rademacher
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

6.  Aberrant expression of GM1 on lymph node cells of MRL/Mp-lpr/lpr mice: influences on the autoreactivities of anti-asialo GM1 antibodies.

Authors:  N Ishii; K Watanabe
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

7.  IgG glycosylation in autoimmune-prone strains of mice.

Authors:  K B Bodman; P R Hutchings; P A Jeddi; P J Delves; G A Rook; N Sumar; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  Agalactosyl glycoforms of IgG autoantibodies are pathogenic.

Authors:  T W Rademacher; P Williams; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

9.  Differential B lymphocyte galactosyltransferase activity in the MRL mouse model of rheumatoid arthritis.

Authors:  J S Axford; A Alavi; A Bond; F C Hay
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

10.  The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn.

Authors:  J L Chu; J Drappa; A Parnassa; K B Elkon
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  5 in total

1.  Fending off decay: a combinatorial approach in intact cells for identifying mRNA stability elements.

Authors:  Z Chrzanowska-Lightowlers; R N Lightowlers
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

2.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

3.  Agalactosyl IgG and beta-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse.

Authors:  P A Jeddi; K B Bodman-Smith; T Lund; P M Lydyard; L Mengle-Gaw; D A Isenberg; P Youinou; P J Delves
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

4.  Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

Authors:  Fabio Dall'Olio; Nadia Malagolini
Journal:  Exp Suppl       Date:  2021

5.  Alteration of N-glycosylation in the kidney in a mouse model of systemic lupus erythematosus: relative quantification of N-glycans using an isotope-tagging method.

Authors:  Noritaka Hashii; Nana Kawasaki; Satsuki Itoh; Yukari Nakajima; Toru Kawanishi; Teruhide Yamaguchi
Journal:  Immunology       Date:  2008-08-14       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.